| Authors: |
Genitsaridi E; Rinri Therapeutics Ltd., Sheffield, UK. eleni.genitsaridi@rinri-therapeutics.com., Papoutselou E; Rinri Therapeutics Ltd., Sheffield, UK. efstratia.papoutselou@rinri-therapeutics.com.; National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham, UK. efstratia.papoutselou@rinri-therapeutics.com.; Hearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK. efstratia.papoutselou@rinri-therapeutics.com., Campbell-Bell CM; Rinri Therapeutics Ltd., Sheffield, UK., Abbas L; Rinri Therapeutics Ltd., Sheffield, UK.; Centre for Stem Cell Biology and School of Biosciences, University of Sheffield, Sheffield, UK., Haines R; Rinri Therapeutics Ltd., Sheffield, UK., Hartley DEH; Rinri Therapeutics Ltd., Sheffield, UK.; National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham, UK.; Hearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.; Nottingham University Hospitals NHS Trust, Nottingham, UK., Rivolta MN; Rinri Therapeutics Ltd., Sheffield, UK.; Centre for Stem Cell Biology and School of Biosciences, University of Sheffield, Sheffield, UK. |